Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral diazepam prophylaxis to prevent recurrent post-vaccination febrile seizures
IRCT20210619051624N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of diazepam in febrile seizure (FS) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Incidence of fever after vaccination, Incidence of seizure after vaccination and 3 more. Started Sep 2021; status: completed.
02
Drugs
diazepam
03
Conditions
febrile seizure (FS)
Beyond the preview
Go deeper on IRCT20210619051624N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210619051624N1.